Literature DB >> 21532181

Quality of life as an independent predictor for cardiac events and death in patients with heart failure.

Naoko Kato1, Koichiro Kinugawa, Satomi Seki, Taro Shiga, Masaru Hatano, Atsushi Yao, Yasunobu Hirata, Keiko Kazuma, Ryozo Nagai.   

Abstract

BACKGROUND: Little is known about health-related quality of life (QOL) in Japanese patients with heart failure. The purpose of this study was to identify factors related to QOL using a disease-specific QOL instrument, and to clarify whether QOL independently predicts clinical outcomes among Japanese patients with heart failure. METHODS AND
RESULTS: A total of 114 outpatients with heart failure were enrolled (mean age 64.7 ± 15.8 years; 73.7% males). The Minnesota Living with Heart Failure Questionnaire (MLHFQ) to assess patient's QOL was used. At baseline, depressive symptoms and chronic kidney disease were significantly associated with worse QOL in multiple regression analysis. During a 2-year follow up, patients with a MLHFQ score ≥ 26, indicating worse QOL, had a higher incidence of the combined endpoint of cardiac death or hospitalization for heart failure, and a higher all-cause mortality than those with a score < 26 (25.3% vs. 7.5%, P = 0.011; 18.5% vs. 6.4%, P = 0.018; respectively). Multivariate Cox proportional hazard models demonstrated that a higher MLHFQ score was significantly associated with increased risks of cardiac events (hazard ratio, 1.02, 95% confidential interval, 1.001-1.05, P = 0.038) and of all-cause death (hazard ratio, 1.04, 95% confidential interval, 1.02-1.07, P = 0.001).
CONCLUSIONS: Depressive symptoms and chronic kidney disease are major determinants of impaired QOL, and the MLHFQ score is an independent predictor of both cardiac events and death among Japanese patients with heart failure.

Entities:  

Mesh:

Year:  2011        PMID: 21532181     DOI: 10.1253/circj.cj-10-1308

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  25 in total

1.  Medical factors that predict quality of life for young adults with congenital heart disease: What matters most?

Authors:  Jamie L Jackson; Lauren Hassen; Gina M Gerardo; Kathryn Vannatta; Curt J Daniels
Journal:  Int J Cardiol       Date:  2015-09-30       Impact factor: 4.164

2.  Impact of diabetes mellitus on quality of life in patients with congestive heart failure.

Authors:  Buntaro Fujita; Alexander Lauten; Bjoern Goebel; Marcus Franz; Michael Fritzenwanger; Markus Ferrari; Hans R Figulla; Friedhelm Kuethe; Christian Jung
Journal:  Qual Life Res       Date:  2011-10-16       Impact factor: 4.147

3.  Myocardial fibrosis and quality of life in patients with non-ischemic cardiomyopathy: a cardiovascular magnetic resonance imaging study.

Authors:  Razi Khan; David Massel; John Stirrat; David Scholl; Gerald Wisenberg; Terry Thompson; Maria Drangova; James A White
Journal:  Int J Cardiovasc Imaging       Date:  2012-08-09       Impact factor: 2.357

4.  Pre-operative health status and outcomes after continuous-flow left ventricular assist device implantation.

Authors:  Kelsey M Flint; Daniel D Matlock; Kartik S Sundareswaran; Joann Lindenfeld; John A Spertus; David J Farrar; Larry A Allen
Journal:  J Heart Lung Transplant       Date:  2013-10-08       Impact factor: 10.247

5.  Physical health status measures predict all-cause mortality in patients with heart failure.

Authors:  Alanna M Chamberlain; Sheila M McNallan; Shannon M Dunlay; John A Spertus; Margaret M Redfield; Debra K Moser; Robert L Kane; Susan A Weston; Véronique L Roger
Journal:  Circ Heart Fail       Date:  2013-04-26       Impact factor: 8.790

6.  Slow breathing improves cardiovascular reactivity to mental stress and health-related quality of life in heart failure patients with reduced ejection fraction.

Authors:  Kamila Lachowska; Jerzy Bellwon; Joanna Moryś; Marcin Gruchała; Dagmara Hering
Journal:  Cardiol J       Date:  2019-01-30       Impact factor: 2.737

7.  Limited association between perceived control and health-related quality of life in patients with heart failure.

Authors:  Teesta Banerjee; Kyoung Suk Lee; Steven R Browning; Claudia Hopenhayn; Susan Westneat; Martha J Biddle; Cynthia Arslanian-Engoren; Jo-Ann Eastwood; Gia Mudd; Debra K Moser
Journal:  J Cardiovasc Nurs       Date:  2014 May-Jun       Impact factor: 2.083

8.  The prognostic value of health-related quality of life in patients with Chagas heart disease.

Authors:  Henrique Silveira Costa; Márcia Maria Oliveira Lima; Pedro Henrique Scheidt Figueiredo; Ana Thereza Chaves; Maria Carmo Pereira Nunes; Manoel Otávio da Costa Rocha
Journal:  Qual Life Res       Date:  2018-08-30       Impact factor: 4.147

9.  Impact of pharmaceutical care on the quality of life of patients with heart failure due to chronic Chagas disease: Randomized clinical trial.

Authors:  Mayara da Costa Chambela; Mauro Felippe Felix Mediano; Fernanda Martins Carneiro; Roberto Rodrigues Ferreira; Mariana Caldas Waghabi; Verônica Gonçalves Mendes; Luciano de Souza Oliveira; Marcelo Teixeira de Holanda; Andréa Silvestre de Sousa; Andréa Rodrigues da Costa; Sérgio Salles Xavier; Gilberto Marcelo Sperandio da Silva; Roberto Magalhães Saraiva
Journal:  Br J Clin Pharmacol       Date:  2019-11-27       Impact factor: 4.335

10.  Impact of pharmaceutical care on the quality of life of patients with Chagas disease and heart failure: randomized clinical trial.

Authors:  Gilberto M Sperandio da Silva; Mayara C Chambela; Andrea S Sousa; Luiz Henrique C Sangenis; Sergio S Xavier; Andréa R Costa; Pedro Emmanuel A A Brasil; Alejandro M Hasslocher-Moreno; Roberto M Saraiva
Journal:  Trials       Date:  2012-12-27       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.